Synthesis Development of the Selective Estrogen Receptor Degrader (SERD) LSZ102 from a Suzuki coupling to a C-H activation strategy

The development of the synthetic process to the selective estrogen receptor degrader (SERD) drug candidate LSZ102 from the medicinal chemistry synthesis to the streamlined large-scale manufacturing...